Can a ginkgo pill protect the aging brain? new trial aims to find out.
NCT ID NCT07287852
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study tests whether a daily pill made from Ginkgo Biloba extract (Egb761) can lower blood markers of Alzheimer's disease in people with mild memory problems. Fifty participants will take the drug twice a day for six months and have regular checkups. The goal is to see if the treatment reduces brain-disease activity and improves thinking and daily function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hadassah medical Center
Jerusalem, 91120, Israel
Conditions
Explore the condition pages connected to this study.